Terms ending in 2030
Every in-force patent on Celeniv Pte. Ltd.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,071,135 | Placental Tissue Compositions In force · High confidence | Celeniv Pte. Ltd. | In force | High confidence | |
| US 9,255,248 | Method of Producing Erythrocytes Without Feeder Cells In force · High confidence | Celeniv Pte. Ltd. | In force | High confidence | |
| US 8,105,634 | Umbilical Cord Biomaterial for Medical Use In force · High confidence | Celeniv Pte. Ltd. | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.